BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21168927)

  • 1. Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for anal carcinoma: are there differences between HIV-positive and HIV-negative patients in the era of highly active antiretroviral therapy?
    Fraunholz I; Rabeneck D; Gerstein J; Jäck K; Haberl A; Weiss C; Rödel C
    Radiother Oncol; 2011 Jan; 98(1):99-104. PubMed ID: 21168927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for invasive anal carcinoma in human immunodeficiency virus-positive patients receiving highly active antiretroviral therapy.
    Fraunholz I; Weiss C; Eberlein K; Haberl A; Rödel C
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1425-32. PubMed ID: 19744801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy.
    Wexler A; Berson AM; Goldstone SE; Waltzman R; Penzer J; Maisonet OG; McDermott B; Rescigno J
    Dis Colon Rectum; 2008 Jan; 51(1):73-81. PubMed ID: 18066626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.
    Seo Y; Kinsella MT; Reynolds HL; Chipman G; Remick SC; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):143-9. PubMed ID: 19203845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anal carcinomas in HIV-positive patients: high-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy.
    Blazy A; Hennequin C; Gornet JM; Furco A; Gérard L; Lémann M; Maylin C
    Dis Colon Rectum; 2005 Jun; 48(6):1176-81. PubMed ID: 15906137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of chemoradiotherapy for anal cancer in patients with HIV infection: oncological outcomes, immunological status, and the clinical course of the HIV disease.
    Fraunholz IB; Haberl A; Klauke S; Gute P; Rödel CM
    Dis Colon Rectum; 2014 Apr; 57(4):423-31. PubMed ID: 24608297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of squamous cell carcinoma of the anal cancer with associated human immunodeficiency virus].
    Sueda K; Ikenaga M; Miyazaki M; Yasui M; Mishima H; Tsujie M; Omiya H; Miyamoto A; Hirao M; Takami K; Fujitani K; Nakamori S; Yoshida K; Tsujinaka T
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2656-8. PubMed ID: 21224670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy.
    Oehler-Jänne C; Huguet F; Provencher S; Seifert B; Negretti L; Riener MO; Bonet M; Allal AS; Ciernik IF
    J Clin Oncol; 2008 May; 26(15):2550-7. PubMed ID: 18427149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: outcomes and toxicities.
    Edelman S; Johnstone PA
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):206-11. PubMed ID: 16904522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and toxicity of chemoradiation in the treatment of HIV-associated anal cancer.
    Hauerstock D; Ennis RD; Grossbard M; Evans A
    Clin Colorectal Cancer; 2010 Oct; 9(4):238-42. PubMed ID: 20920996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug eruption (erythema multiforme type) following chemoradiotherapy with mitomycin C and 5-fluorouracil administration for squamous cell carcinoma of the anal canal].
    Arikawa S; Uchida M; Ogoh E; Uozumi J; Yoshida S; Watanabe Y; Kaida H; Ishibashi N; Shirouzu K; Hayabuchi N
    Gan To Kagaku Ryoho; 2010 Apr; 37(4):727-30. PubMed ID: 20414036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-associated anal squamous cell cancer: an otherwise preventable disease.
    Konstantinopoulos PA; Schlecht HP; Bryan B; Pantanowitz L; Dezube BJ
    J Clin Oncol; 2006 Sep; 24(27):4516-7. PubMed ID: 16983122
    [No Abstract]   [Full Text] [Related]  

  • 13. Node-negative T1-T2 anal cancer: radiotherapy alone or concomitant chemoradiotherapy?
    Zilli T; Schick U; Ozsahin M; Gervaz P; Roth AD; Allal AS
    Radiother Oncol; 2012 Jan; 102(1):62-7. PubMed ID: 21993403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermoid anal cancer prognosis comparison among HIV+ and HIV- patients.
    Abramowitz L; Mathieu N; Roudot-Thoraval F; Lemarchand N; Bauer P; Hennequin C; Mitry E; Romelaer C; Aparicio T; Sobhani I
    Aliment Pharmacol Ther; 2009 Aug; 30(4):414-21. PubMed ID: 19392867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance of patients with human immunodeficiency virus and anal carcinoma to treatment with combined chemotherapy and radiation therapy.
    Holland JM; Swift PS
    Radiology; 1994 Oct; 193(1):251-4. PubMed ID: 8090901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage surgery for residual primary and locally recurrent anal squamous cell carcinoma after chemoradiotherapy in HIV-positive individuals.
    Cunin L; Alfa-Wali M; Turner J; Bower M; Ion L; Allen-Mersh T
    Ann Surg Oncol; 2014 Feb; 21(2):527-32. PubMed ID: 24242676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
    Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Four cases of anal squamous cell carcinoma treated by chemoradiotherapy].
    Sato H; Maeda K; Koide Y; Matsuoka H; Noro T; Honda K; Shiota M; Endo T; Ozeki S; Fukuda M
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2647-9. PubMed ID: 21224667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy for epidermoid carcinoma of the anus: thirty years' experience.
    Myerson RJ; Outlaw ED; Chang A; Birnbaum EH; Fleshman JW; Grigsby PW; Kodner IJ; Malayapa RS; Mutch MG; Parikh P; Picus J; Tan BR
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):428-35. PubMed ID: 19251377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of anal canal carcinoma].
    Thang NN; Cochet S; George AC; Betz M; Roth A
    Rev Med Suisse; 2011 May; 7(296):1144-8. PubMed ID: 21721205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.